Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of a continuous intravenous
(IV) ularitide infusion on the clinical status and outcome of patients with acute
decompensated heart failure (ADHF).